World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 November 2024
Main ID:  NCT02463344
Date of registration: 13/05/2015
Prospective Registration: No
Primary sponsor: Astellas Institute for Regenerative Medicine
Public title: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Scientific title: Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Advanced Dry AMD
Date of first enrolment: February 25, 2013
Target sample size: 11
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02463344
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Medical Director
Address: 
Telephone:
Email:
Affiliation:  Astellas Institute for Regenerative Medicine
Key inclusion & exclusion criteria
Inclusion Criteria:

- Must have been treated with hESC-RPE cell transplant in the core protocol.

- Able to understand and willing to sign the informed consent to participate in the
follow up study.

Exclusion Criteria:

- There are no exclusion criteria.



Age minimum: 55 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Age-Related Macular Degeneration
Intervention(s)
Biological: MA09-hRPE
Primary Outcome(s)
Safety assessed by Adverse Events (AEs) of special interest in regards to the investigational product [Time Frame: 4 years]
Secondary Outcome(s)
Incidence of graft failure or rejection [Time Frame: 4 years]
Number of patients with changes in ocular examinations or images [Time Frame: 4 years]
Secondary ID(s)
ACT MA09-hRPE AMD -001 LTFU
7316-CL-0005
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history